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1 Abstract 
Osteoarthritis (OA) is a whole joint disease that affects all knee joint tissues. Ligaments, a matrix-rich 
connective tissue, play an important mechanical function that stabilises the knee joint and yet their role 
in OA is not well studied. Recent studies have shown that ligament extracellular matrix (ECM) structure 
is compromised in the early stages of OA, but it remains unclear how this affects ligament function and 
biomechanics. In this study, the aim was to investigate the structural, cellular and viscoelastic changes 
in the anterior cruciate ligament (ACL) in a murine non-invasive post-traumatic OA (PTOA) model. 
Non-invasive mechanical loading of the knee joint of C57BL/6J mice (10-week-old) was used as a 
PTOA model. Knee joints were analysed for joint space mineralisation and the ACLs were assessed 
with histology and mechanical testing. PTOA knee joints had a 33-46% increase in joint space 
mineralisation and PTOA knee joint ACLs exhibited ECM modifications, including collagen 
birefringence and COL2 and proteoglycan deposition. ECM changes were associated with cells 
expressing chondrogenic markers (SOX9 and RUNX2) expanding from the tibial enthesis to the ACL 
midbody. Viscoelastic and mechanical changes in the ACLs from PTOA knee joints included a 20-21% 
decrease in tangent modulus at 2MPa of stress, and a decrease strain rate sensitivity at higher strain 
rates and a significant increase in relaxation during stress-relaxation, but no changes to hysteresis and 
ultimate load to failure. These results demonstrate that ACL pathology and viscoelastic function is 
compromised in murine PTOA knee joints and provides further evidence of the important role of 
ligaments in the knee joint organ in health and disease. 
  
2 Introduction 
Osteoarthritis (OA) is a degenerative joint disease that affects the whole knee joint (Loeser et al., 2012), 
including loss of articular cartilage, osteophyte formation, subchondral bone remodelling, synovial 
hyperplasia and ligament degeneration. Ligaments are the main stabilizers of the knee joint (Frank, 
2004), however their role in OA progression is largely unexplored. Previously, we showed structural 
and pathological changes in the cruciate and collateral knee ligaments of murine OA mouse models 
(Ramos-Mucci et al., 2020), similar to the pathology described in human OA anterior cruciate ligaments 
(ACLs) (Hasegawa et al., 2013; Hasegawa et al., 2012). These structural and pathological changes 
could alter the ligament mechanical function and ultimately induce further OA. 
Tissue structure and mechanical function are closely related, including in ligaments (Frank, 2004). 
Ligaments are composed of a collagen hierarchical structure made of primarily collagen type I as well 
as noncollagenous extracellular matrix (ECM) proteins such as proteoglycans, elastin and glycolipids 
(Frank, 2004). Ligaments are viscoelastic and demonstrate viscoelastic properties such as: 1) strain rate 
sensitivity, where mechanical behaviour is stiffer at higher strain rates, 2) stress-relaxation, where stress 
reduces under constant deformation, 3) creep, where deformation occurs under a constant load and 4) 
hysteresis, where there are differences in the loading and unloading behaviour (Woo, 1982). 
Viscoelastic behavior is mainly attributed to collagen interaction with ECM structural proteins such as 
proteoglycans and elastin (Elliott et al., 2003; Franchi et al., 2007; Robinson et al., 2004). Specifically, 
ECM changes that affected viscoelastic properties of ligaments or tendons include collagen (Connizzo 
et al., 2015; Sun et al., 2015), proteoglycans (Connizzo et al., 2013) and elastin content (Henninger et 
al., 2015).  
The consequences of the OA disease process on the mechanical behaviour of ligaments are not fully 
understood. To date, there are few studies that characterise the mechanical properties of the ACL in OA 
knee joints. In human knee OA patients, one study found a decrease in elastic stiffness and an increase 
in viscoelastic stress-relaxation in ACLs (Hagena et al., 1989). In the Dunkin Hartley guinea pig 
spontaneous OA model, there were reduction in the viscoelastic toe-region laxity of the ACLs compared 
to healthy controls (Quasnichka et al., 2005). In STR/ort spontaneous OA mice, ACLs had a lower 
ultimate load compared to healthy control knee joints (Anderson-MacKenzie et al., 1999). These studies 
confirm a decrease in stiffness and ultimate load in the ACL of OA knee joints but did not measure 
other physiologically relevant viscoelastic properties of the ACL (Franchi et al., 2007). 
Murine models offer several advantages to study OA progression. The post-traumatic OA (PTOA) 
model developed by Poulet et al. offers the ability to test the ACL mechanical properties post-trauma 
without invasive ligament transection (Poulet et al., 2011). The PTOA mouse knee joint is known to 
develop OA in the lateral knee compartment with moderate severity following two weeks of non-
invasive loading of the knee joint (Poulet et al., 2011). The pathological and mechanical properties of 
the ACL have not previously been studied in the PTOA knee joint. 
There is a lack of knowledge of the ligament cellular microenvironment and its surrounding structural 
and mechanical niche. Understanding these components can help us understand biomechanical 
pathways in the ligaments driving ligament degeneration and potentially knee joint OA progression. 
We hypothesise that changes in the ACL ECM composition and structure during OA development will 
result in reduced stiffness and modifications of their viscoelastic properties. The aim of this study was 
to characterise the ACL mechanical, matrix and cellular environment during murine PTOA pathology, 
to better understand PTOA disease processes for future therapeutical interventions. 
 
3 Materials and Methods 
3.1 Post-traumatic osteoarthritis (PTOA) murine model 
Non-invasive joint loading was performed on the right knees of ten-week-old C57BL/6 mice (Charles 
River, UK) to induce OA and articular cartilage lesions as has been previously shown (Poulet et al., 
2011). Briefly, axial 9N compressive loads were applied for forty cycles in each loading episode, and 
six loading episodes over a period of two weeks. Mice were kept under general gas anaesthesia 
(isoflurane) for the entire procedure, which lasts about 10 minutes.  
For joint space mineralisation quantification, knee joints were analysed at 4 (n=7) and 14 (n=4) weeks 
after the last loading episode, to determine progressive changes following OA induction. C57/BL6 male 
mice at 14 and 24 weeks of age were used as age-matched controls (n=4 per group). 
For ACL histology and mechanical testing, knee joints were analysed six weeks after the last loading 
episode. From the PTOA mice (n=12 total); n=8 of the right loaded legs were used for ACL mechanical 
testing, and n=4 right loaded legs for µCT (micro-computed tomography) ACL measurements. From 
the non-loaded mice, right legs were used for ACL mechanical testing (n=8), and left legs for µCT ACL 
measurements (n=4). Left knee joints were used to measure ACL measurements, as it has been 
previously shown that contralateral ACLs are an appropriate surrogate to for anatomical dimensions 
(Jamison et al., 2010). 
All mice were kept in the same conditions in polypropylene cages, subjected to 12-hour light/dark 
cycles, at 21±2˚C and fed standard diet ad libitum. For tissue collection, animals were euthanised by 
cervical dislocation. All procedures were performed in accordance with the UK Home Office guidelines 
and regulations under the Animals (Scientific Procedures) Act 1986 and local ethics committee (project 
license: P267B91C3). 
 
3.2 Measuring knee joint space mineralisation in the murine PTOA knee joint 
Knee joint mineralisation was quantified as previously described (Ramos-Mucci et al., 2020). PTOA 
knee joint were analysed at 4 and 14-weeks post-trauma. Briefly, cadaveric knee joints were fixed 
(neutral buffered formalin) and dehydrated (in 70% ethanol) and then were scanned using a Skyscan 
1172 µCT scanner (Skyscan, Belgium) with a 5µm isotropic voxel size (50kV, 200µA respectively, 
0.5mm Aluminium filter; 0.6° rotation angle, no frame averaging). Regions of interests of the knee joint 
comprising of menisci and ligaments were hand-drawn and quantified using CTAn (Skyscan, Belgium) 
(Ramos-Mucci et al., 2020). Statistical analysis of mineralised volume of the murine knee joint was 
performed using a one-way ANOVA and post-hoc analysis to compare control and PTOA knee joints 
at 4 and 14-weeks post-trauma (significance was set at p < 0.05). Three-dimensional models of the 
mineralised tissue were created using CTVox from the region of interest selected for mineralised tissue 
volume analysis (Skyscan, Belgium). 
 
3.3 Histological and immunohistochemical assessment of the murine knee joint 
For histology, fixed (neutral buffered formalin) joints were decalcified (ImmunocalTM, Quarttet, 
Berlin, Germany), dehydrated and processed for wax embedding. Serial coronal 6µm thick sections 
were cut across the entire joint. Slides were stained with toluidine blue (TB) to assess 
pathophysiological changes in the knee joint (Glasson et al., 2010) and picrosirius red to assess collagen 
birefringence (Junqueira et al., 1979). TB staining consisted of 0.1% TB in 0.1M solution of acetate 
buffer, pH 5.6 for 15 minutes and counterstained with 0.2% fast green for 5 seconds and then rinsed 
with acetone twice for 10 seconds. For picrosirius red, sections were stained in Weigert’s haematoxylin 
for 8 minutes then stained with picrosirius red solution (0.1% w/v sirius red in saturated aqueous picric 
acid) for one hour and then washed with 0.5% v/v glacial acetic acid in distilled water for 3 minutes. 
Slides were then dehydrated, mounted and imaged with an Olympus microscope with an adjustable 
polariser (Olympus BX60). 
Immunohistochemistry was performed to localise expression of collagen type II (COL2) (Thermo, 
Mouse MC), SOX9 (Millipore, Rabbit PC), RUNX2 (Abcam, Rabbit PC) and asporin (ASPN) (Abcam, 
Rabbit PC), as described previously (Ramos-Mucci et al., 2020). For COL2, antigen retrieval was 
applied with pepsin (3mg/mL in 0.02M HCl) for 45 minutes at 37ᵒC. Slides were then blocked for 
endogenous peroxidase with 0.3% hydrogen peroxide (Sigma, 15 minutes), for endogenous 
Avidin/Biotin binding with an Aviding/Biotin Blocking Kit (Vector Labs, SP2001; 15 minutes each), 
and for non-specific binding sites (COL2: blocking solution from MoM Kit, Vector Labs, BMK-2202; 
SOX9, RUNX2, ASPN: 10% v/v goat serum). Primary antibodies were incubated overnight at 4°C and 
included COL2 (1/100), SOX9 (1/1000), RUNX2 (1/1000), ASPN (1/400). Negative controls included 
a mouse IgG (2µg/mL, Sigma) or rabbit IgG (1µg/mL, Vector Labs). Biotinylated secondary antibody 
(Vector Labs; 1/200 for 1h) and then Vectastain solution (Vector Labs) were applied. Stains were 
developed with DAB (Vector Labs), dehydrated, mounted in DPX and imaged with a Zeiss microscope 
(Zeiss). 
 
3.4 Murine anterior cruciate ligament (ACL) imaging and measurements 
Mouse knee joints were analysed with µCT to quantify the murine ACL length and cross-sectional area 
(CSA). PTOA knee joint ACL samples from the right loaded knee joint were used (n=4), and in the 
healthy control group ACL samples from the left knee joint were used (n=4). Low sample number of 
ligaments is a potential limitation of this method. Immediately after death, skin was removed from the 
hind limb and was frozen and kept at -20℃ until analysis. The knee joints were defrosted and dissected 
under a microscope until only the femur-ACL-tibia complex remained. Femur-ACL-tibia samples were 
submerged in Lipiodol contrast agent (Guerbet, FR) overnight at 4℃. Sample was fitted into a small 
straw holder filled with Lipiodol and a putty adhesive (Blu Tack) was used to keep the femur in place 
at a 90º angle with the ACL and tibia suspended vertically. The femur-ACL-tibia samples were then 
scanned with a 5µm isotropic voxel size (50kV, 200µA respectively, 0.5mm Aluminium filter; 0.6° 
rotation angle, no frame averaging) using a Skyscan 1172 µCT scanner (Bruker, BE). This is similar to 
previous methods using contrast agents to image the mouse knee joint (Das Neves Borges et al., 2014). 
A sagittal area of interest, showing the femoral condyles-ACL-and tibia condyles, was used to measure 
ACL length using the CTan software (Bruker) (Fig. 1A, yellow arrow). A second area of interest of the 
entire ACL volume was selected in the Dataviewer software (Bruker) and saved in the axial plane for 
analysis of the ACL CSA.  The ACL CSA was measured using the CTan software (Bruker) at the ACL 
midsection (Fig. 1A, yellow arrow). An average ACL length and CSA was calculated for each mouse 
group and these were used to calculate stress-strain. 
 
 
Figure 1: Murine anterior cruciate ligament (ACL) imaging and mechanical testing setup. A) Murine ACL 
was visualised with µCT imaging with a contrast agent and used to measure length and cross-sectional area (CSA) 
(yellow arrows). B) Mechanical testing setup included custom-made clamps, which allowed for poly(methyl 
methacrylate) fixation of the femur and tibia at a 90° angle and for vertical alignment of the ACL. C) Fixed 
samples were loaded into a dual column uniaxial machine (Instron) for mechanical testing of the ACL. D) 
Mechanical testing protocol used for viscoelastic and material behaviour of the ACL which included 
preconditioning cycles, strain rate testing at 0.1%/s, 1%/s and 10%/s strain rates, stress-relaxation loaded to 5% 
strain and lastly ultimate load to failure was tested at 1%/s until ACL rupture. 
 
3.5 Mechanical testing of the murine anterior cruciate ligament (ACL) 
Murine ACL mechanical properties were analysed with a customised clamp and tensile testing system 
(Fig. 1B), designed based on past literature (Anderson-MacKenzie et al., 1999; Connizzo et al., 2015; 
Sun et al., 2015; Warden et al., 2006). The clamp was manufactured in steel at the School of 
Engineering at the University of Liverpool. 
Immediately following death, murine hind legs were stored at -20ᵒC. Storage at this temperature has 
been previously shown to not influence the viscoelastic and mechanical properties of ligaments (Moon 
et al., 2006; Woo et al., 1986). On the day of measurement, knee joints were defrosted and dissected 
until only the femur-ACL-tibia complex remained. Poly(methyl methacrylate) (PMMA) (Technovit 
6091) was used to fix the femur and tibia, to approximate 90º of knee flexion (Fig. 1B). This extent of 
knee flexion was within the physiological range of mouse knee flexion (Sup. Table 1) and allowed for 
uniform tensile testing along the axis of the ligament (Warden et al., 2006).  
The femur-ACL-tibia was briefly aligned under the dissection microscope to ensure a vertical ACL 
orientation (Fig. 1B). The fixture with the sample was transferred to a dual column uniaxial material 
testing machine (Instron 3366, USA) with a 10N load cell. The encasing outer covering enclosed the 
sample and PBS was added to ensure a hydrated ligament sample (Fig. 1C).  
The mechanical testing protocol applied a preload of 0.02N to remove laxity in the ligament, followed 
by a series of 10 preconditioning cycles at a strain rate of 1%/s to a maximum load of 0.4N, which 
ensured ligaments were in a steady state condition (Fung, 1993) (Fig. 1D). Following preconditioning, 
strain rate sensitivity, stress-relaxation behaviour and ultimate load at failure were tested (Fig. 1D). For 
strain rate testing, two load-unload cycles of three different strain rates were applied (0.1%/s, 1%/s, and 
10%/s) (Fig. 1D). These strain rates have been used in previous studies on murine ACLs (Anderson-
MacKenzie et al., 1999; Sun et al., 2015). Viscoelastic stress-relaxation was tested at 5% strain (applied 
strain at 1%/s) and elongation was maintained while monitoring load, similar to a previous study 
(Connizzo et al., 2015). Elongation was maintained for 120 seconds where stress-relaxation behaviour 
started to stabilise (Fig. 1D). Lastly the ultimate load at failure was tested by increasing the load on the 
specimen while maintaining a strain rate of 1%/s until ligament rupture took place (Fig. 1D). 
Analyses of the load-elongation data were performed on Microsoft Excel (version 2109). Stress, strain 
tangent modulus and hysteresis values were calculated as previously described (Elsheikh et al., 2008; 
Readioff et al., 2020). Average ACL length and CSA measurements were used for all these calculations 
(Section 3.4 and Sup. Table 2).  
For stress-strain behaviour, the ACL length and CSA measurements for the PTOA and control ACL 
were used to calculate the stress and strain using Equations 1 and 2, respectively. The resulting stress-
strain curve was then fitted to an exponential curve suitable for ligament stress-strain behaviour (Haut 
and Little, 1969) using the least squares method. From the exponential best-fit curve for each strain 






   (Equation 1) 





   
(Equation 2) 
where ε is strain (mm/mm), ∆L is the corresponding change in elongation (mm) (∆L = Lt – L0), L0 is 
the initial estimated ligament length (mm), and Lt is the deformed length of the ligament (mm). 
 





where Etan is tangent modulus (MPa). 
To determine the sensitivity of stress-strain behaviour to changes in strain rate, estimations of the stress-
strain behaviour and tangent modulus were repeated for all the different strain rates (0.1%/s, 1%/s, 
10%/s). Tangent modulus values were normalised to the 0.1%/s strain rate tangent modulus of the same 
sample using Equation 4.  
 





where Enorm(σ) is the normalised tangent modulus (%) at a specific stress, Etan(σ) is the tangent modulus 
at 1%/s or 10%/s strain rates at the corresponding stress, and E0(σ) is the tangent modulus at 0.1%/s 
strain rate at the corresponding stress. 
Stress-relaxation behaviour was characterised by monitoring the stress degradation over time while 
maintaining a strain of 5%. Stress was normalised by the peak stress at t=0 (when 5% strain was 
reached) (Connizzo et al., 2015) using Equation 5. The stress-relaxation curve was fitted into a 
polynomial equation to determine the average normalised stress for all samples. 
 𝜎𝑛𝑜𝑟𝑚(𝑡) =  
𝜎𝑡
𝜎0
 (Equation 5) 
where σnorm(t) is the normalised stress (MPa/MPa) over log time, σo the peak stress at t=0 and σt is the 
stress behaviour over log time. 
Hysteresis was calculated from the load-elongation data to measure the area between the load and 
unload cycles which correlates to the energy dissipated due to material viscosity. Hysteresis was 
measured using numerical integration (trapezoidal rule) as described previously (Elsheikh et al., 2008; 
Readioff et al., 2020). 
3.6 Statistical analysis  
For statistical analysis of the ACL viscoelastic properties (stress-strain, tangent modulus, strain rate 
sensitivity, normalised strain rate sensitivity), measurements were analysed at specified stress or strains. 
For stress-relaxation the area under the curve was calculated using numerical integration and used to 
compare control and PTOA ACL properties. 
Normality and statistical analysis were calculated using GraphPad Prism (GraphPad v8) (GraphPad 
Software, CA, USA). Data normality was assessed with Shapiro–Wilk tests. For ACL CSA and length 
measurements, an unpaired t-test was used to compare between control and test groups. Data was not 
normally distributed for the stress-strain of the PTOA and control group, and therefore, a nonparametric 
statistical test was performed (Mann-Whitney test). A nonparametric Friedman test was used when 
comparing the stress-strain at the three different strain rates, followed by a Dunn’s multiple comparison 
test. All other ACL properties showed normal distribution and an unpaired t-test (two tailed) was 
performed to compare between control and test groups. A repeated measures ANOVA was used when 
comparing the tangent modulus-stress and hysteresis at different strain rates, followed by a Bonferroni 
post-hoc test. For stress-relaxation, when comparing the area under the curve of the normalised tangent 
modulus of the 1%/s and the 10%/s strain rates, a paired t-test (two-tailed) was used. A Friedman test, 
repeated measures ANOVA and paired t-test were possible since measurements were taken from the 
same ACL at different strain rates. Significance was set at p < 0.05. 
 
4 Results 
4.1 Knee joint space mineralisation increased with PTOA disease progression 
Calcified and ossified tissues in the murine knee joint was visualized and quantified using µCT imaging. 
The non-invasive PTOA knee joint had increased mineralisation compared to healthy control knee 
joints at both 4-(33% increase, p<0.01) and 14-weeks (46% increase, p<0.001) following trauma (Fig. 
2A). Mineralisation also significantly increased at 14 weeks post-trauma compared to 4 weeks post-
trauma (p=0.02) (Fig. 2A), suggestive of progressive OA pathology. Furthermore, representative 
reconstructed 3D µCT images demonstrated the mineralisation was localised primarily to the lateral 
and posterior menisci and meniscal ligaments (Fig. 2B) and these increases in knee joint space 
mineralisation were indicate structural changes to knee joint tissues following trauma. 
 
 
Figure 2: Quantification and 3D images of joint space mineralisation in post-traumatic OA (PTOA) murine 
knee joints using µCT analysis. A) The volume of mineralised tissue in the joint space increased between the 4 
and 14 weeks timepoints of post-traumatic OA (following 2 weeks of repetitive trauma loading) compared to non-
loaded healthy controls. B) 3D enlargement of the meniscus and ectopic mineralisation nodules showed 
mineralisation in the lateral and posterior compartments of the knee joint. 
 
4.2 Histological assessment of the PTOA ACL revealed cellular hypertrophy and expression of 
chondrogenic markers 
Histological staining of the knee joint revealed differences in structural and cellular composition of 
healthy and PTOA knee joints ligaments. In the healthy control knee joints, the ACL midsubstance 
comprised of spindle-shaped cells with aligned fibres that stain only weakly with TB (Fig. 3A) and 
green collagen birefringence (Fig. 3E). In the healthy ACL-tibial enthesis region, there were 
fibrocartilaginous cells with rounded morphology surrounded by TB staining (Fig. 3A, black arrow) 
and red collagen birefringence (Fig. 3E). In the PTOA knee joint, the ACL midsubstance had consistent 
stronger TB staining and cells with rounded cell morphology (Fig. 3B, yellow arrow). Furthermore, in 
the PTOA ACL-tibial enthesis there was a distinct TB region encompassing cells with rounded 
morphology (Fig. 3B, black arrow), which corresponded with red collagen birefringence that extended 
towards the midbody region (Fig. 3F, blue arrows). Increases in TB staining and red collagen 
birefringence in the diseased ACL indicate a change in ECM composition and organisation with disease.  
 
Figure 3: Representative histological staining in the anterior cruciate ligament (ACL) of control and post-
traumatic OA (PTOA) murine knee joints. A-B) Toluidine blue (Tol. Blue) staining of healthy control ACL 
and PTOA ACL showed toluidine blue staining in the midsubstance and in the tibial enthesis of the PTOA ACL 
(black arrow). C-D) Brightfield Picrosirius Red (BF Pic. Red) staining confirmed rounded-cell morphology in the 
tibial enthesis of the PTOA ACL (black arrow). E-F) Polarised Picrosirius Red (Pol Pic. Red) showed red collagen 
birefringence in the tibial enthesis extending towards the midsubstance of the PTOA ACL (yellow arrows). Scale 
is 100um and 50um for the low and higher magnification images, respectively. 
 
To further understand these ECM changes, staining for specific matrix and cellular markers, via 
immunohistochemistry, confirmed modifications to ECM composition with PTOA. Collagen type II 
(COL2) was present as expected in the fibrocartilaginous region of the ACL-tibial enthesis of the 
healthy control (Fig. 4C, black arrow). In the PTOA knee joint, COL2 staining expanded from the ACL-
tibial enthesis (Fig. 4D) towards the ACL midsubstance region (Fig. 4E, black arrow). Cellular changes 
were also confirmed in the PTOA knee joint and included expression of chondrogenic marker SOX9, 
hypertrophic marker RUNX2, and small-leucine rich proteoglycan (SLRP) Asporin (ASPN). Both 
SOX9 and RUNX2 expression was faint in the healthy control ACL-tibial enthesis (Fig. 4F, I), but were 
clearly expressed in cells at the ACL-tibial enthesis (Fig. 4G, J) and ACL midsubstance (Fig. 4H, K) in 
the PTOA knee joint. Similarly, pericellular ASPN expression was found in the healthy control knee 
joint in the ACL-tibial enthesis in limited cells (Fig. 4L), but ASPN expression was found throughout 
the ACL (black arrows) and in surrounding regions (red arrow) (Fig. 4M-N) in the PTOA knee joint. 
Immunohistochemistry confirmed changes to the ECM composition and cellular phenotype in diseased 
mouse ACL, with strong suggestions of early endochondral ossification pathways being activated 
(SOX9, COL2, ASPN). 
 
 
Figure 4: Representative marker expression in the anterior cruciate ligament (ACL) of control and post-
traumatic OA (PTOA) murine knee joints with immunohistochemistry. A-B) The ACLs of healthy control 
knee joints and PTOA knee joints (B) where analysed at the tibial enthesis (black box) and midbody (yellow box) 
regions. C-E) Collagen type II (COL2) expression was present in the fibrocartilaginous tibial enthesis of the 
healthy control ACL and in the tibial enthesis and mid-body regions of the PTOA ACL (black arrows). F-H) 
SOX9 chondrogenesis transcriptional factor expression was also found in the tibial enthesis and mid-body regions 
of the PTOA ACL (black arrows). I-K) RUNX2 hypertrophic transcriptional factor was expressed in the tibial 
enthesis region of the PTOA ACL (black arrows). L-N) Asporin (ASPN), a small leucine-rich proteoglycan, was 
expression in the tibial enthesis of the control ACL and extended within the mid-substance of the PTOA ACL. 
Scale is 25um for immunohistochemistry (higher magnification), and 50um for A-B (lower magnification). 
4.3 Viscoelastic stiffness decreased, strain rate sensitivity decreased, and relaxation increased 
in the murine PTOA knee joint ACL 
Mechanical properties of murine ACLs following PTOA development were assessed and compared to 
healthy controls. Stress-strain plots of behaviour at strain rates of 0.1%/s, 1%/s and 10%/s showed 
exponential viscoelastic behaviour in healthy control ACLs (Fig. 5A). PTOA ACLs also demonstrated 
similar viscoelastic behaviour and stress was compared to healthy control ACLs at several strains. At 
0.03 mm/mm strain, the midpoint, stress in the PTOA ACLs was not significantly different from the 
control ACLs at any strain rate (p=0.19 for 0.1%/s, p=0.20 for 1%/s, p=0.21 for 10%/s) (Fig. 5A). 
However, the tangent modulus-stress plots, which provide stiffness estimates at different stress levels, 
demonstrated reductions in the tangent modulus in diseased ACLs. At 2MPa stress, the midpoint, the 
tangent modulus was significantly decreased by 20% at 0.1%/s strain rate relative to control ACLs 
(p=0.03), 20% at 1%/s strain rate (p=0.02), and 21% at 10%/s strain rate (p=0.02) (Fig. 5B). These 
results suggest a decrease in ACL stiffness in the toe-region of the PTOA knee joint stress-strain 
behaviour compared to the healthy control ACL. 
Strain-rate sensitivity was also analysed in the stress-strain, tangent modulus-stress, and normalised 
tangent modulus-stress curves. In the stress-strain curves, at 0.03 mm/mm strain, no significant 
differences were found between different strain rates in the control ACLs (p=0.17) and the PTOA ACLs 
(p=0.28) (Fig. 5A). In the tangent modulus-stress curves, strain-rate differences were statistically 
significant at 2 MPa stress for both the control (p<0.01) and the PTOA ACLs (p<0.01) (Fig. 5B), 
suggestive of strain rate sensitivity in both ACL groups. However, post-hoc analysis comparing specific 
strain rates revealed differences at higher strain rates. In the PTOA ACLs, at 2 MPa of stress, there was 
no statistical differences between the 0.1%/s and 1%/s strain rates and the 1%/s and 10%/s strain rates 
(p=0.15 for both). In the control ACLs, at 2 MPa, post-hoc analysis showed statistical differences 
between all strain rates (p<0.01 for all). This would suggest a decrease in strain rate sensitivity in the 
PTOA ACLs. Normalised tangent modulus-stress curves confirmed these findings as strain rate 
differences between 1%/s and 10%/s led to significant differences in results at 2MPa of stress in the 
control ACLs (p<0.01) but not in the PTOA ACLs (p=0.07) (Fig. 5C) suggestive of a decrease in strain 
rate sensitivity in the PTOA ACLs at higher strain rates. 
The normalised stress in stress-relaxation tests was lower throughout the stress-relaxation response in 
the diseased ACLs compared to the healthy control ACLs (p=0.04) (Fig. 5D). This was indicative of an 
increased relaxation response of the PTOA ACLs compared to the healthy ACLs. 
When comparing the hysteresis response between the control and PTOA ACLs, there were no statistical 
differences at 0.1%/s (p=0.09), 1%/s (p=0.08) and 10%/s (p=0.88) (Fig. 5E). Furthermore, negative 
hysteresis was found in the 10%/s strain rate for both the control and PTOA ACLs (Fig. 5E). Therefore, 
changes in viscoelastic behaviour were seen in the stress-relaxation but not hysteresis. 
 
  
Figure 5: Mechanical and viscoelastic properties of the anterior cruciate ligament (ACL) of control and 
post-traumatic OA (PTOA) murine knee joints. A-B) Average stress-strain and tangent modulus-stress curves 
showed a decrease in stiffness at all strain rates for the PTOA ACLs compared to the control ACLs. C) Normalised 
tangent modulus-stress curves (normalised from the 0.1%/s strain rate curve) compared differences in 1%/s and 
10%/s strain rates, which were statistically significant in the control ACLs (p<0.01) but not in the PTOA ACLs 
(0=0.07), suggesting a lack of strain rate sensitivity between 1%/s and 10%/s of the PTOA ACL. D) Stress-
relaxation curves showed lower normalised stress in the PTOA ACLs. E) Hysteresis curves at different strain rates 
showed no statistical difference between control and PTOA (0.1%/s: p=0.09, 1%/s: p=0.08, 10%/s: p=0.88). F) 
Ultimate load at failure showed no statistical difference between control and PTOA ACLs. Legend: Control = 
black, PTOA = red. 
 
The material strength of the ACL was also measured with the ultimate load to failure, which was similar 
in the healthy control and PTOA ACLs. The ultimate load was 6.17 ±1.91 N and 6.10 ±2.51 N for the 
control and PTOA ACLs respectively (p=0.96) (Fig. 5F). This would imply similar material strengths 
of the control and PTOA ACLs, despite differences in viscoelastic properties. 
Overall, viscoelastic properties of the PTOA ACL demonstrated a decrease in stiffness, strain rate 
sensitivity and normalised stress during stress-relaxation, which reinforces our hypothesis that 
viscoelastic properties of the ACL are modified in the PTOA knee joint. 
 
5 Discussion 
This study found that PTOA induced non-invasively in the murine knee joint resulted in changes in the 
ECM components and viscoelastic mechanical properties of the murine ACL. These findings confirm 
that ACL pathologies do result in functional anomalies, which could in turn contribute to the 
progression of OA. Specifically, we have found that structural changes during PTOA, particularly 
proteoglycan and COL2 deposition, were associated with a decrease in ligament stiffness, a decrease in 
strain rate sensitivity and an increased relaxation behaviour during stress-relaxation. In particular, 
changes in the strain rate sensitivity of the ACL in the PTOA models is, to our knowledge, a novel 
finding and suggests a decrease in stiffness at higher strain rates. 
Increases in joint space mineralisation measured using non-invasive imaging tools (µCT) was used in 
this study as an indicator of OA progression, specifically in the lateral and posterior compartments, 
which correlated with the location of OA development in this PTOA model (Poulet et al., 2011). An 
increase in mineralisation in murine OA joints has been previously shown in other OA models using 
the same µCT-based methodologies (Ramos-Mucci et al., 2020). Indeed, joint space mineralisation in 
the surgical model of PTOA (destabilisation of the medial meniscus, DMM) and in the spontaneous 
model Str/ort mouse was associated with ossification of the menisci and medial collateral ligaments, 
primarily in the medial compartments of the joint, corresponding with initiation of OA development in 
these models. These studies suggest a strong spatial relationship between articular cartilage 
degeneration and pathological joint tissue mineralisation and support the use of joint µCT imaging as 
non-invasive measures of disease progression in vivo. Further studies will determine the molecular and 
cellular basis of this pathological joint mineralisation, including in ligaments, and whether these could 
be targeted to slow disease development. 
Changes in the ACL matrix composition during PTOA included increased TB staining, indicative of 
proteoglycan deposition (Sun et al., 2012), red collagen birefringence and COL2 deposition. Red 
collagen birefringence suggests thicker collagen organisation at the ACL-tibial enthesis (Junqueira et 
al., 1979; Lattouf et al., 2014). Interestingly, these changes in collagen organisation did not result in 
stiffer mechanical properties of the ACL.  Viscoelastic behaviour of the OA murine ACLs showed 
changes in the tangent modulus, strain rate sensitivity and stress-relaxation properties. These changes 
included a significant decrease in the tangent modulus at all strain rates, implying a decrease in 
viscoelastic stiffness. It is likely that ECM components are driving this viscoelastic change, including 
collagen type II deposition. Indeed, collagen type II molecules are generally flexible and have a lower 
elastic modulus (stiffness) than collagen type I molecules (Luo et al., 2004) and therefore could be 
driving the decrease in tangent modulus. However, to truly answer this question, the role of COL2 in 
viscoelastic behaviour needs to be further assessed, including whether COL2 is stretched in the toe 
region and how it interacts with the surrounding matrix. 
Stress-relaxation curves were significantly decreased in our murine osteoarthritic ACLs, indicating an 
increase in relaxation. Changes in viscoelastic stress-relaxation has previously been associated with 
glycosaminoglycan and proteoglycan depletion in tendons (Elliott et al., 2003; Legerlotz et al., 2013). 
Proteoglycan depletion is not likely in the PTOA knee joint ligaments which had an increase in TB 
staining, and therefore could suggest a different matrix component is driving this change in stress-
relaxation. 
Increases in relaxation the ACL stress-relaxation behaviour in human OA and rheumatoid knees have 
been reported previously (Hagena et al., 1989), reinforcing similar viscoelastic mechanical pathology 
between murine and human OA. However, the ACL of OA patients also had a decrease in ultimate load 
(Hagena et al., 1989), not seen in the murine PTOA ACLs. These differences could arise from 
differences in disease severity between our murine OA model (samples taken during active early 
progression of OA) whereas human OA tissues are generally already severe when collected. 
Changes in strain rate sensitivity in ACLs from OA knee joints have not been previously reported. 
Therefore, our study shows for the first time a decrease in the strain rate sensitivity of the higher strain 
rates (1% and 10%/s) which suggests a decrease in the ECM stiffness at higher strain rates. Strain rate 
sensitivity is another viscoelastic property associated with GAG and proteoglycan composition. A 
reduction in strain rate sensitivity has been reported in decorin and biglycan depleted tendons (Elliott 
et al., 2003; Robinson et al., 2017; Robinson et al., 2004). Computational modelling has also supported 
the interfibrillar viscoelastic role of proteoglycans (Redaelli et al., 2003). However, the role of 
proteoglycans and noncollagenous components on viscoelastic behaviour is still debated. Collagen 
fibrils have greater elongation at higher strain rates (Clemmer et al., 2010), and theoretically collagen 
could play a more important role at higher strain rates. Our study also reported asporin expression in 
diseased ACLs, however ASPN lacks GAG chains (Maccarana et al., 2017) usually associated with 
increased viscosity (Kershaw-Young et al., 2013) and therefore is unlikely to play a role in viscoelastic 
behaviour. Further research is needed to fully map proteoglycan and noncollagenous composition in the 
ACL during OA and their role in biomechanics. 
Previous studies have shown that tendon fibroblasts respond to mechanical stimuli by adjusting ECM 
stiffness (Lavagnino et al., 2003; Screen et al., 2005), therefore it is possible that ligament fibroblasts 
are driving this ECM and viscoelastic changes. However, the mechanotransduction pathways involved 
are unknown. This study showed SOX9, RUNX2 and collagen type II expression in the ACL-tibial 
enthesis and midbody of the murine PTOA knee joint, in the same area where we identified cells with 
rounded morphology. These are known markers of chondrogenesis and hypertrophy, crucial for 
endochondral ossification. Asporin is a known tendon and ligament SLRP (Kharaz et al., 2016), also 
found in the cartilage of human OA patients. It plays a role inhibiting TGF-β-induced expression of the 
Col2a1 gene (Kizawa et al., 2005) and is a negative regulator of periodontal ligament mineralisation by 
interacting directly with BMP-2 (Yamada et al., 2007).The presence of asporin in the diseased ACL 
could be an attempt of ligament cells to control pathological chondrogenesis and mineralisation but the 
actual effects of increased asporin in ligaments remains to be explored.  
It is still unclear whether ligament viscoelastic changes contribute to OA progression. Changes to the 
ACL mechanical function will affect joint stability, which could in turn accelerate OA pathology. It is 
clear though that ACL mechanics and OA are closely related. As mentioned previously, changes in 
ACL viscoelasticity and mechanics have also been reported in spontaneous OA models (Anderson-
MacKenzie et al., 1999; Quasnichka et al., 2005). Furthermore, spontaneous OA models also 
demonstrated similar COL2 and SOX9 expression (Ramos-Mucci et al., 2020), suggesting similar 
pathologies in both types of OA. COL2 in ligaments and tendons has been shown to be a result of 
adaptation to compressive load (Benjamin and Ralphs, 1998; Buckley et al., 2013), and therefore could 
be a direct result of the non-invasive loading regime. In addition, COL2 has also been found in human 
OA ligaments (Hasegawa et al., 2013) and guinea pig OA ligaments (Quasnichka et al., 2006). 
Interestingly, it has been shown that changes in the matrix stress-relaxation properties can regulate 
scaffold remodelling and bone formation (Darnell et al., 2017). Therefore, similar viscoelastic changes 
in the ligaments could be driving the chondrogenesis seen in OA ligaments. In this case, changes to the 
ECM mechanical properties could be driving more pathology directly.  
Limitations of this study arise from the mechanical testing of the murine ACL. Stress and strain were 
calculated with the assumption of similar ACL length and CSA within groups, which could affect the 
accuracy of the stress-strain curve. Most other studies on murine ACL mechanics measured the CSA 
and length for each individual sample (Anderson-MacKenzie et al., 1999; Connizzo et al., 2015; Sun 
et al., 2015). The small size of the murine ACL and these inaccuracies could account for the high 
deviation seen in the stress-strain curves and the negative hysteresis measured. Negative hysteresis has 
been previously reported in human tendons (Peltonen et al., 2013; Zelik and Franz, 2017) and attributed 
to testing inaccuracies. However, negative hysteresis was only measured in the faster 10%/s strain rates 
at areas of high stress, similar to what was reported previously in the human Achilles tendon (Peltonen 
et al., 2013). Past studies in human skin have attributed negative hysteresis to varying viscoelastic 
properties of different skin layers (Lamers et al., 2013). The same could potentially apply to the ACL, 
negative hysteresis could be a result of differences in its ligament bundles or fascicles. 
Overall, this research showed that ligament matrix composition and viscoelastic behaviour change in 
PTOA knee joints, potentially driven by cellular expression of chondrogenic and hypertrophic markers 
which could be driving OA progression. Furthermore, we have confirmed our hypothesis that structural 
changes in the ACL resulted in a reduction in viscoelastic stiffness and other viscoelastic properties of 
the ACL. This confirms that the ligament biomechanical microenvironment is altered during OA. 
Understanding the relationship between the structure and mechanical function is necessary to better 
understand the underlying OA pathways. In the future, targeting these molecular and cellular changes 
might improve ligament function and prevent further OA progression. 
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7 Supplementary material 
7.1 Gait analysis of murine knee flexion 
Gait analysis tests to determine the physiological range of motion in the murine knee joint was 
conducted on healthy B6CBAF1 mice (n=4) (Charles River). Biplanar X-ray was recorded using two 
independent 60 kW Epsilon X-ray generators (EMD Technologies, CA), 16 inch image intensifier tubes 
(Thales, FR), X-Ray Tubes (Varian, USA) and Phantom Miro M120 video cameras (Vision Research, 
USA). X-ray images of gait (Sup. Fig. 1A) were analysed using XMALab Software (Brown University, 
USA) and MatLab (MathWorks, R2018a Version 9.4, USA). For each mouse, two gait trials were 
analysed. X-ray generator pulsed radiographic exposures at 120 frames per second, and video was 
recorded for approximately 3 seconds. Video files were corrected for distortion, calibrated and digitised 
in XMALab software. Mouse gait was tracked at every frame at the following points: left hip, left knee, 
left ankle, right hip, right knee, right ankle, and occiput (Sup. Fig. 1B). The resulting locations of each 
point were exported and in MatLab a 3D model was created (Sup. Fig. 1C) and knee speed and knee 
joint flexion was measured at every frame. The results from this gait analysis of physiological murine 
knee flexion were used to determine the ideal physiological angle for mechanical testing of the femur-
ACL-tibia complex.  
 
 
Supplemental Figure 1: Murine knee flexion measurements using biplanar X-ray. A) X-ray images were 
imported to XMALab software (Brown University, USA) where each anatomical point (Pt.) was tracked. B) 
Anatomical points tracked were the following: left hip (1, LHIP), left knee (2, LKNEE), left ankle (3, LANK), 
right hip (4, RHIP), right knee (5, RKNEE), right ankle (6, RANK), and occiput (7, OCCI). C) A 3D model of 
murine gait for the left and right hind-legs was created from which physiological knee range of motion during 
murine gait was calculated. 
 
Maximum knee flexion was 100.8° in the left knee joints and 100.5° in the right knee joint (Sup. Table 
1). Minimum knee flexion was 56.5° and 55.6° in the left and right knee respectively (Sup. Table 1). 
Maximum and minimum angles of knee flexion in both the left and right knee joints of the B6CBAF1 
(n=4) mice were similar. This data suggests that the physiological range of murine knee flexion during 
gait was between 55-100°. In order to remain within the physiological range, mechanical viscoelastic 
and material testing of the murine ACL was performed at 90° of knee flexion, because it allowed for 
uniform tensile testing along the axis of the ligament, similar to a previous study by Warden et al 
(Warden et al., 2006). 
 
Supplemental Table 1. Angles of murine knee joint flexion and gait speed as determined by biplanar 
radiography. The average minimum (Min) and maximum (Max) knee flexion was calculated in degrees for both 
the left and right murine knee joint. Knee flexion ranged from 56.5 to 100.8° in the left knee, and 55.6 and 100.5° 
in the right knee joint. Relative standard deviation (RSD) ranged from 6.7% to 13.3%.  
 Degrees (°) Gait speed 
 Min Max Min Max (mm/s) 
 Left Knee Right Knee Left knee Right knee 
Avg. 56.5 100.8 55.6 100.5 135.6 138.7 
RSD (%) 8.8 13.3 6.7 11.5 24.3 19.1 
 
7.2 Anterior cruciate ligament (ACL) measurements of PTOA knee joints 
ACL length and CSA were measured using µCT imaging. The ACL length of the control and PTOA 
knee joint ACLs was 1.14 ±0.10 mm and 1.09 ±0.09 mm respectively and were not significantly 
different (p=0.08). The ACL CSA was 0.105 ±0.017 mm2 for the control knee joint and 0.109 ±0.017 
mm2 for the PTOA knee joint and were not significantly different (p=0.6) (Sup. Table 2). The ACL 
measurements for each murine group were used to calculate their viscoelastic properties. 
 
Supplemental Table 2. Murine knee joint anterior cruciate ligament (ACL) measurements. Measurements 
of the ACL were taken from healthy and PTOA knee joints and included ACL length and ACL cross-sectional 
area (CSA). For each measurement relative standard deviation (RSD) and percent different (%diff) was calculated. 
CSA and length of control and PTOA ACLs were not significantly different (p=0.6 for CSA, and p=0.08 for 
length). 
 
